Your browser doesn't support javascript.
loading
Combination therapy with afatinib and bevacizumab in an EGFR-mutated non-small cell lung cancer patient with acquired ERBB2 amplification: A case report.
Chen, Sixian; Xiang, Tianmin; Lu, Wei; Hong, Shuiqiang; Li, Yuanyuan; Lu, Yuan; Zhang, Qiongyue; Chen, Yongfeng; Zhou, Suli; Wang, Gehui; Zhang, Zhenzhen; Cai, Yongguang.
Afiliação
  • Chen S; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
  • Xiang T; Singlera Genomics Inc., Shanghai, China.
  • Lu W; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
  • Hong S; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
  • Li Y; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
  • Lu Y; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
  • Zhang Q; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
  • Chen Y; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
  • Zhou S; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
  • Wang G; Singlera Genomics Inc., Shanghai, China.
  • Zhang Z; Singlera Genomics Inc., Shanghai, China.
  • Cai Y; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang.
Medicine (Baltimore) ; 100(8): e24380, 2021 Feb 26.
Article em En | MEDLINE | ID: mdl-33663050
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Bevacizumab / Antineoplásicos Imunológicos / Afatinib / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Bevacizumab / Antineoplásicos Imunológicos / Afatinib / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article